From a clinical point of view, plasma GlycA, IL-6, TNF and IFN-γ are promising candidate biomarkers for immunomonitoring of inflammaging in PLHTLV-1, and of disease progression and corticosteroid therapeutic response in HAM/TSP patients, respectively. Here, TNF is linked to tropical spastic paraparesis.